4.7 Article

Novel Insights into the Global Proteome Responses of Insulin-Producing INS-1E Cells To Different Degrees of Endoplasmic Reticulum Stress

Journal

JOURNAL OF PROTEOME RESEARCH
Volume 9, Issue 10, Pages 5142-5152

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/pr1004086

Keywords

Type 1 diabetes; 2D-DIGE; INS-1E; endoplasmic reticulum stress

Funding

  1. Catholic University of Leuven (GOA) [2004/10, 2009/10]
  2. Flemish Research Foundation (FWO) [G.0552.06, G.0649.08]
  3. Belgium Program on Interuniversity Poles of Attraction initiated by the Belgian State [IUAP P5/17, P6/40]
  4. Centre of Excellence SymBioSys [EF/05/007]
  5. Juvenile Diabetes Research Foundation International [1-2008-536]
  6. European Union
  7. European Community
  8. NAIMIT
  9. Forskningsradet for Sunned og Sygdom
  10. NICHD [HD055150-03]
  11. [E06D100904BR]

Ask authors/readers for more resources

Exposure of insulin-secreting beta-cells to inflammatory cytokines or high concentrations of free fatty acids, factors involved in the pathogenesis of type 1 and type 2 diabetes, leads to endoplasmic reticulum (ER) stress, beta-cell dysfunction, and eventually apoptotic beta-cell death. The aim of this study was to investigate the impact of ER stress on beta-cells at the protein level to evaluate the contribution of post-transcriptional and post-translational changes in ER stress-induced beta-cell damage. INS-1E cells were exposed in vitro to the ER-stress inducer cyclopiazonic acid (CPA) at two concentrations, and protein changes were evaluated using 2D-DIGE. CPA, 25 mu M, led to massive apoptosis, accompanied by a near complete protein translation shut-down. CPA, 6.25 mu M, led to adaptation of the beta-cells to ER stress. Identification of the differentially expressed proteins in the two conditions led to the discovery of a clear pattern of defense pathways, with post-translational modifications playing a crucial role. Key alterations included inhibition of insulin translation and post-translational modifications in ER chaperones HYOU1 and HSPA5. Also, a central role for 14-3-3 proteins is suggested. In conclusion, INS-1E cells are highly sensitive to ER stress, leading to important post-transcriptional and post-translational modifications that may contribute to beta-cell dysfunction and death.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

The use of glucagon-like-peptide-1 receptor agonist in the cardiology practice

Pieter Martens, Chantal Mathieu, Thomas Vanassche

Summary: The presence of type 2 diabetes puts patients at a higher risk for cardiovascular disease, heart failure, and chronic kidney disease. Glucose control alone is not enough to prevent these complications, but new drugs like SGLT2-I and GLP-1RA show promise in reducing these risks. However, the uptake of these drugs in clinical practice, especially GLP-1RA, is low.

ACTA CARDIOLOGICA (2023)

Review Endocrinology & Metabolism

Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes

Athena Philis-Tsimikas, Harpreet S. Bajaj, Kamilla Begtrup, Roman Cailleteau, Amoolya Gowda, Ildiko Lingvay, Chantal Mathieu, David Russell-Jones, Julio Rosenstock

Summary: This article describes the clinical development program ONWARDS phase 3a, which investigates the use of once-weekly basal insulin icodec in the treatment of type 2 and type 1 diabetes. Six trials are being conducted to evaluate the efficacy and safety of icodec, with consideration of different clinical scenarios and comparator treatments.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Low Gestational Weight Gain in Women With Gestational Diabetes Is Safe With Better Metabolic Profile Postpartum

Caro Minschart, Astrid Lammertyn, Paul Van Crombrugge, Carolien Moyson, Johan Verhaeghe, Sofie Vandeginste, Hilde Verlaenen, Chris Vercammen, Toon Maes, Els Dufraimont, Nele Roggen, Christophe De Block, Yves Jacquemyn, Farah Mekahli, Katrien De Clippel, Annick Van Den Bruel, Anne Loccufier, Annouschka Laenen, Roland Devlieger, Chantal Mathieu, Katrien Benhalima

Summary: The level of gestational weight gain (GWG) during pregnancy is associated with adverse pregnancy outcomes in women with gestational diabetes (GDM) compared to women with normal glucose tolerance (NGT). Low GWG below recommended levels frequently occurs in GDM women without increased risk for adverse outcomes. Excessive GWG is associated with increased risk for neonatal hypoglycemia and worse metabolic profile postpartum in GDM women, and with higher rates of instrumental delivery and larger infants in NGT women.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Endocrinology & Metabolism

Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes

Alexandra Coomans de Brachene, Corentin Scoubeau, Anyishai E. Musuaya, Jose Maria Costa-Junior, Angela Castela, Julie Carpentier, Vitalie Faoro, Malgorzata Klass, Miriam Cnop, Decio L. Eizirik

Summary: This study reveals the unexpected potential of exercise training to preserve the health of beta cells, opening up a new avenue for preventing or slowing down the progression of diabetes through muscle-beta cell communication.

DIABETOLOGIA (2023)

Letter Endocrinology & Metabolism

Women in diabetes research: we can do better. Reply to Bonnefond A [letter]

Chantal Mathieu, Stefano Del Prato

DIABETOLOGIA (2023)

Editorial Material Endocrinology & Metabolism

The changing landscape of scientific communication at EASD

Chantal Mathieu, Eleanor Kennedy, Patrick Schrauwen, Hindrik Mulder

DIABETOLOGIA (2023)

Editorial Material Endocrinology & Metabolism

The European Diabetes Forum (EUDF): a forum for turning the tide on diabetes in Europe

Chantal Mathieu, Jeannette Soderberg, Stefano Del Prato, Anne-Marie Felton, Xavier Cos, Carine de Beaufort, Jean-Francois Gautier, Bastian Hauck, Angus Forbes, Robert Heine, Peter Schwarz, Bart Torbeyns

DIABETOLOGIA (2023)

Article Cell Biology

Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis

Kerstin Griess, Michael Rieck, Nadine Muller, Gergely Karsai, Sonja Hartwig, Angela Pelligra, Robert Hardt, Caroline Schlegel, Jennifer Kuboth, Celina Uhlemeyer, Sandra Trenkamp, Kay Jeruschke, Jurgen Weiss, Leon Peifer-Weiss, Weiwei Xu, Sandra Cames, Xiaoyan Yi, Miriam Cnop, Mathias Beller, Holger Stark, Arun Kumar Kondadi, Andreas S. Reichert, Daniel Markgraf, Marianne Wammers, Dieter Haeussinger, Oliver Kuss, Stefan Lehr, Decio Eizirik, Heiko Lickert, Eckhard Lammert, Michael Roden, Dominic Winter, Hadi Al-Hasani, Doris Hoeglinger, Thorsten Hornemann, Jens C. Bruning, Bengt-Frederik Belgardt

Summary: Impaired proinsulin-to-insulin processing in pancreatic beta-cells is a key defective step in both type 1 diabetes and type 2 diabetes. This study reveals the roles of specific sphingolipid species and sphingolipid-binding proteins in beta-cell function and T2D-associated beta-cell failure.

NATURE CELL BIOLOGY (2023)

Article Endocrinology & Metabolism

Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?

Decio L. Eizirik, Florian Szymczak, Roberto Mallone

Summary: In type 1 diabetes, pancreatic beta-cells are destroyed by the immune system, while neighboring alpha-cells are spared. The key differences between these cells, including the expression of antiapoptotic genes, ER stress-related genes, viral recognition and innate immune response genes, and immune-inhibitory molecules, contribute to the different vulnerabilities to autoimmune destruction and the preferential survival of alpha-cells.

NATURE REVIEWS ENDOCRINOLOGY (2023)

Article Immunology

Oral administration of helminth fluid modulates distinct tuft cell and immune-metabolic cues linked to reduced body fat

Daniel Andersen, Janne Marie Moll, Pankaj Arora, Niels Banhos Danneskiold-Samsoe, Si Brask Sonne, Christopher Thomas Workman, Andrew Richard Williams, Karsten Kristiansen, Susanne Brix

Summary: Intestinal tuft cells and immune responses were examined in mice fed a high-fat diet and gavaged with helminth PCF. Helminth PCF upregulated gene expression in tuft cells and increased levels of innate lymphoid cells and eosinophils. Network analyses revealed immunometabolic cues linking tuft cell response to fat mass ratio and eosinophils in eWAT to body fat mass regulation.

PARASITE IMMUNOLOGY (2023)

Review Cardiac & Cardiovascular Systems

Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society

Andrea M. Yeung, Jingtong Huang, Ambarish Pandey, Ibrahim A. Hashim, David Kerr, Rodica Pop-Busui, Connie M. Rhee, Viral N. Shah, Lia Bally, Antoni Bayes-Genis, Yong Mong Bee, Richard Bergenstal, Javed Butler, G. Alexander Fleming, Gregory Gilbert, Stephen J. Greene, Mikhail N. Kosiborod, Lawrence A. Leiter, Boris Mankovsky, Thomas W. Martens, Chantal Mathieu, Viswanathan Mohan, Kershaw Patel, Anne Peters, Eun-Jung Rhee, Giuseppe M. C. Rosano, David B. Sacks, Yader Sandoval, Jane Jeffrie Seley, Oliver Schnell, Guillermo Umpierrez, Kayo Waki, Eugene E. Wright Jr, Alan H. B. Wu, David C. Klonoff

Summary: The Diabetes Technology Society assembled a panel of clinician experts to review the current evidence on biomarker screening of people with diabetes for heart failure and provide recommendations for diagnosis and management to prevent disease progression.

PROGRESS IN CARDIOVASCULAR DISEASES (2023)

Article Biochemistry & Molecular Biology

Genetic effects on molecular network states explain complex traits

Matthias Weith, Jan Grossbach, Mathieu Clement-Ziza, Ludovic Gillet, Maria Rodriguez-Lopez, Samuel Marguerat, Christopher T. Workman, Paola Picotti, Jurg Baehler, Ruedi Aebersold, Andreas Beyer

Summary: The complexity of cellular and organismal traits is a result of the integration of genetic and environmental factors through molecular networks. While the structure and propagation of effects in networks are best understood at the level of functional modules, there is currently no established concept to include the global network state.

MOLECULAR SYSTEMS BIOLOGY (2023)

Meeting Abstract Endocrinology & Metabolism

Sustained improvement of glycaemic control and patient-reported outcomes after 12 months of advanced hybrid closed-loop in type 1 diabetes in real-world

J. De Meulemeester, M. M. Visser, B. Keymeulen, C. Vercammen, M. Strivay, G. Vanhaverbeke, C. De Block, L. Van Huffel, L. Winne, I. Lowyck, K. Spincemaille, R. Radermecker, D. Ballaux, C. Mathieu, P. Gillard

DIABETOLOGIA (2023)

Article Mathematics, Applied

Smoothing unadjusted Langevin algorithms for nonsmooth composite potential functions

Susan Ghaderi, Masoud Ahookhosh, Adam Arany, Alexander Skupin, Panagiotis Patrinos, Yves Moreau

Summary: This paper proposes a gradient-based Markov Chain Monte Carlo (MCMC) method for sampling from the posterior distribution of problems with nonsmooth potential functions. By using smoothing techniques, the original potential function is approximated by a smooth function with the same critical points, leading to a smoothing ULA method called SULA. Non-asymptotic convergence results of SULA are established under mild assumptions on the original potential function. Numerical results demonstrate the promising performance of SULA on both synthetic and real chemoinformatics data.

APPLIED MATHEMATICS AND COMPUTATION (2024)

Review Medicine, Research & Experimental

Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review

Laura M. Jacobsen, Jennifer L. Sherr, Elizabeth Considine, Angela Chen, Sarah M. Peeling, Margo Hulsmans, Sara Charleer, Marzhan Urazbayeva, Mustafa Tosur, Selma Alamarie, Maria J. Redondo, Korey K. Hood, Peter A. Gottlieb, Pieter Gillard, Jessie J. Wong, Irl B. Hirsch, Richard E. Pratley, Lori M. Laffel, Chantal Mathieu, I ADA EASD PMD

Summary: Jacobsen, Sherr et al. evaluate the utility of novel technologies in the treatment of type 1 diabetes. Their systematic review finds technologies such as continuous glucose monitoring, insulin pumps, and decision support tools improve important measures (e.g., HbA1c, time in range, quality of life) allowing precision-directed uptake of technology.

COMMUNICATIONS MEDICINE (2023)

No Data Available